Clinical Trial Update: Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 safety and proof-of-concept study of the experimental drug RPT1G in adults with acute myeloid leukemia and high-risk myelodysplastic syndromes is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• RPT1G

Snippet

Sponsor: Remedy Plan, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: RECRUITING